Quick Links
Advocacy Award Information
NEW AWARD CATEGORY FOR 2021
As part of the Society's 40th Anniversary celebrations, we are announcing a new Award Category. The Advocacy Award will recognise the outstanding impact by an individual or a team in the alcohol, tobacco, and other drugs sector who works in the policy and/or advocacy area.
This is the first APSAD Award open to teams and the recipient of the 2021 Advocacy Award will have the opportunity to hold an Advocacy Workshop at the 2021 APSAD Brisbane Conference.
Details for the new Advocacy Award:
The Advocacy Award recognises the outstanding impact by an individual or a team in the alcohol, tobacco, and other drugs sector who works in the policy and/or advocacy area.
Eligibility
- Any individual or team who has made an outstanding impact in policy and/or advocacy in the alcohol, tobacco and other drugs field, and can demonstrate one or more of the achievements below;
- Positive advancement in the understanding of alcohol, tobacco and other drugs issues in a given community or population group, or
- Advocacy for an advancement that is in the public interest (public health or welfare and/or criminal justice), evidence based (evidence that it will work as intended), and has a focus on reducing drug related harm, or
- Positive policy change for the alcohol, tobacco and other drugs field. Change could occur in the following areas but are not limited to; legislative, government, and community, or
- Strategy formation, e.g. strategic thinking, coalition formation, government liaison, key messaging.
Selection Criteria
Evidence of the impact made in the alcohol, tobacco and other drugs field. The nomination should clearly describe the achievements to be honoured, the scope and depth of the impact, and the processes used by the nominee, including for instance strategy formation and the use of evidence to underpin the advocacy/policy.
Further Details:
- Nominations can be for any individual or team that meets the criteria for the Advocacy Award category.
- APSAD Membership is not a prerequisite, nor is it of any advantage or disadvantage during the nomination process.
- The nominator must be a current (financial) member of APSAD. Any member can nominate across multiple Award Categories.
- Nominations close 7 September 2021, the Award recipient is announced in October and is given the opportunity to organise a workshop at the 40th APSAD Conference in Brisbane.
- The Recipients for all Award Categories are announced at the official Awards Ceremony held during the 40th APSAD Conference in Brisbane on 8-10 November.
Head to the Awards page for the Information pack and nomination form.
Lived & Living Experience Award
NEW LIVED & LIVING EXPERIENCE AWARD CATEGORY
To celebrate the APSAD Awards 20th anniversary we are announcing the new Lived and Living Experience Award. The Lived and Living Experience Award will recognise an individual that has made an important contribution to clinical practice, research, training, prevention, or policy in their role as someone with lived experience working or volunteering in the area of substance use or harm reduction services.
Lived & Living Experience Award details:
The Lived and Living Experience Award recognises an individual that has made an important contribution to clinical practice, research, training, prevention, or policy in their role as someone with lived experience working or volunteering in the area of substance use or harm reduction services.
Eligibility
Any individual who is employed or volunteering in an identified lived or living experience role within in the alcohol and other drugs sector is eligible to apply. Individuals must be drawing on their lived and/or living experience of alcohol and/or other drug use in the service of others. Five or more years of lived or living experience is preferred, but applicants with less experience may still be considered.
Note: people with lived and living experience are encouraged to nominate in the other award categories – Senior Scientist, Early-Career, Mid-Career, Mentor, Clinician, First Nations, and Advocacy.
Selection Criteria
Evidence of significant contribution to practice, research, training, prevention, or policy in any aspect of substance use working (or volunteering) in a recognised lived or living experience role. Nominees need to show the extent of the impact of their work and how it has made a substantial and practical contribution to one of these areas. The nomination should clearly describe the achievements to be honoured, the scope and depth of impact, including evidence of significant positive impact on outcomes for consumers and/or service provision in the AOD sector.
Examples:
- Demonstrating improvements in policy, practice, research, or workforce
- Advocating for the rights of people who use alcohol and other drugs
- Increasing access and retention to AOD and harm reduction services
Further Details:
- APSAD Membership is not a prerequisite, nor is it of any advantage or disadvantage during the nomination process.
- The nominator must be a current APSAD member. Any member can nominate across multiple Award categories.
- Nominations close 29 July 2024.
- The recipients for all APSAD Awards are announced at the official Awards Ceremony held during the 2024 APSAD Conference on Ngunnawal Country (Canberra) 30 Oct -2 Nov.
Head to the Awards page for more Information or go straight to the nomination form.
2020 Award highlights
With the cancellation of this year's APSAD conference due to COVID-19 the annual APSAD Awards ceremony was held online.
APSAD President Professor Michael Farrell presented the 2020 APSAD Awards for Excellence in Science, Research and Practice at the special online ceremony. The six recipients of the APSAD Awards are recognised as having made an outstanding contribution to reducing the harms associated with alcohol and other drug use in Australasia.
2020 APSAD AWARD RECIPIENTS
 Senior Scientist Award Robert Ali
|
 L to R: Mid Career Award
Suzanne Nielsen &
Mentor Award Paul Dietze
|
 First Peoples Award
Robert Assan
|
 Clinician Award Anthony Gill
|
 Early Career AwardCheneal Puljević
|
Senior Scientist Award A/Prof Robert Ali
Associate Professor Robert Ali ( MBBS FAFPHM, FAChAM DPH) is a public health physician and specialist in addiction medicine. Until October 2016 he was the clinical director of Drug & Alcohol Services South Australia; a role he held for 30 years. Currently he is a Senior Research Fellow at the University of Adelaide. Robert is a member of the Australian National Advisory Council on Alcohol and Drugs, member of the Cochrane Alcohol and Drug Group editorial board and the WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems.
The Senior Scientist Award is for a scientist who has made an outstanding contribution to the field of substance use.
Mid Career Award A/Prof Suzanne Nielsen
Associate Professor Suzanne Nielsen (BPharmSc[Hons] PhD MPS) is the Deputy Director of the Monash Addiction Research Centre in Melbourne, and is a current NHMRC Career Development Fellow. Suzi has been a registered pharmacist for over 20 years with clinical experience in the treatment of substance use disorders includes in specialist drug treatment and community-based alcohol and drug treatment settings in Australia and the United Kingdom. She has published over 135 scientific publications and given over 170 national and international conference presentations on her research, which has led to a greater understanding of how to identify and respond to prescription and over-the-counter drug-related problems. Her recent work has a focus on reducing opioid-related harm and overdose prevention. Suzi has worked with Australian state and federal governments to reduce opioid-related and other drug harm.
The Mid Career Award is for significant contribution in the alcohol and other drug field.
Early Career Award Dr Cheneal Puljević
Dr Cheneal Puljević is a Research Fellow at the Centre for Health Services Research and the School of Public Health at the University of Queensland. At the Centre for Health Services Research she is the Program Manager for the Global Substance Use and Mental Health unit, where she conducts and manages a number of research projects related to substance use, including the Queensland evaluation of the Tackling Alcohol-Fuelled Violence Policy (QUANTEM), and several projects using data from the Global Drug Survey. At the School of Public Health, she is the co-coordinator of the CARP smoking cessation trial, and contributes to projects promoting smoking cessation among priority populations. Her primary research interest is smoking cessation among disadvantaged populations, with her PhD (completed in 2018) and current UQ Early Career Researcher Grant focusing on this topic. (https://researchers.uq.edu.au/researcher/22250)
The Early Career Award is for excellence in research relative to career opportunities.
Mentor Award Prof Paul Dietze
Professor Paul Dietze is one of Australia’s leading alcohol and other drug epidemiologists with a significant national, and emerging international profile. He is an NHMRC Senior Research Fellow and a past ARC Future Fellow and VicHealth Public Health Research Fellow. With more than 20 years’ experience and an outstanding track record, his work has established internationally innovative surveillance systems and applied research designs that break new ground in the public health research into alcohol and other drug use and related harms in Australia. He has produced more than 290 journal articles along with many other reports of significant impact that have changed practice in the area of alcohol and other drugs in this country. During the course of his research career he has received more than $20 million of research funding. (https://www.burnet.edu.au/people/174_paul_dietze)
The Mentor Award recognises an individual who has made an important contribution to mentoring and supporting the career development of clinicians, researchers or students.
First Peoples Award Robert Assan
I am both Aboriginal and Torres Strait Islander. I was born in the Northern Territory, but my cultural background is from Thursday Island.
Training has been a big part of my work. And it gives me great satisfaction – working with health workers and seeing them come along in their ability to help individuals and families around alcohol and drugs. I have been able to offer training and support to Aboriginal and Torres Strait Islander workers around Australia, and to many other staff. The training helps them work with Aboriginal or Torres Strait Islander people with alcohol or drug problems. I have also worked with individuals and communities, in the Northern Territory and in Queensland, to help them rethink their alcohol or drug use.
My current work involves both training and support of health workers, and one-to-one work with adolescents. This work is at the Cleveland Youth Detention Centre in Townsville. I like that sense of planting the seed that leads to change later on. You don’t always see the results straight away, but the seed is there. The young people are able to use that information that you’ve given them. I equip people with knowledge and skills and insight that can help them in life.
Recognises an individual that has made an important contribution to the advancement of the health of Aboriginal, Torres Strait Islander and Māori peoples.
Clinician Award Dr Anthony Gill
Dr Anthony (Tony) Gill is an Addiction Medicine Specialist who has worked in the Drug and Alcohol field for around 30 years. He has worked as a clinician and clinical leader primarily. He has held various Drug and Alcohol Clinical Director positions in NSW Local Health Districts and in the past in the NSW Ministry of Health. He is presently a Senior Staff Specialist in the Alcohol and Drug Service at St Vincent’s Hospital Sydney, and Chief Addiction Medicine Specialist in the NSW Ministry of Health. His interests in drug and alcohol include teaching and clinical service development and redesign, and he has worked extensively with general practitioners to enhance their activities in drug and alcohol.
Recognises excellence and leadership in clinical practice in the field of substance use in any discipline.
2018 APSAD Award Highlights
2018 APSAD Award Winners announced
The APSAD Conference Dinner and Awards was held at Maritime Room Auckland. The recipients of the APSAD Awards are recognised as having made an outstanding contribution to reducing the harms associated with alcohol and other drug use in Australasia. It is a special experience to formally acknowledge the dedication of our peers and celebrate the quality of their work.
"She is a champion for health equity and an advocate for gender equity and this is reflected not only in her research outputs but in her approach to building the capacity of new researchers. Her supportive approach is highly effective; her students and mentees achieve remarkable success in their careers and progress to make substantial contributions to tobacco research and the community in general. She is an inspiring role model (her young female ECR twitter followers refer to her as their "research idol") not only for productivity and achieving career goals, but also for showing them how to ensure their research makes a meaningful difference to people's lives. Evidence of the effectiveness of her mentoring is in the metrics: she has supervised 19 students, 15 of those PhD students, all on PhD scholarships, and 7 winning awards for PhD excellence from their institutions (University of Newcastle, Monash) or national awards (eg, Council of Australian Public Health Institutions, Cancer Institute NSW)."
2019 APSAD Award Highlights
The APSAD Conference and Awards Dinner was held at the Brooke Street Pier situated on Sullivans Cove in the waterfront area of Hobart.
APSAD President Professor Michael Farrell presented the 2019 APSAD Awards for Excellence in Science, Research and Practice. The recipients of the APSAD Awards are recognised as having made an outstanding contribution to reducing the harms associated with alcohol and other drug use in Australasia. It is a special experience to formally acknowledge the dedication of our peers and celebrate the quality of their work.
Kate Conigrave; Adrian Dunlop (back); Mark Montebello
Dr Catherine Quinn graduated with a Combined PhD and Clinical Masters in Psychology from Macquarie University in 2015. She currently holds an industry-funded Lives Lived Well Research Fellowship at the School of Psychology, University of Queensland and is a registered clinical psychologist. Dr Quinn is currently working closely with Lives Lived Well, a large alcohol and other drug treatment service, examining the efficacy of novel evidence-based interventions across community and residential treatment settings and the factors that impact their effective implementation.
Michael is a Bardi person and Wingara Mura Research Fellow at the University of Sydney. Michael began his health career when he enrolled into the Aboriginal Health Worker training program in the Kimberley, while working in the general store of his home community of Djarindjin in 1997. Since then, Michael has worked in men’s health in the Aboriginal community controlled sector in Western Australia. He was worked for the Aboriginal Health Council of Western Australia and helped establish the peak body for Aboriginal community controlled health services in that state. Michael continues to work closely with colleagues in the Aboriginal community-controlled health sector. This includes serving as a member of the Aboriginal Health and Medical Research Council of NSW Human Research Ethics Committee. Michael has worked in research on alcohol and other drugs since 2008, including at the National Drug Research Institute, the Kirby Institute at the University of New South Wales. Since 2017 Michael has worked at the University of Sydney in the Centre of Research Excellence in Indigenous Health and Alcohol.